GERN Q4 2021 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+1980.0% YoY

Gross Profit

-$22M-2106.9% margin

Operating Income

-$31M-2979.0% margin

Net Income

-$32M-3078.6% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+854.1%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$226M

Total Liabilities

$100M

Stockholders' Equity

$126M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$50,000	+1980.0%
Gross Profit	-$22M	-$15M	-48.6%
Operating Income	-$31M	-$23M	-33.2%
Net Income	-$32M	-$24M	-34.6%